en Science Society & Culture nonadult Weekly podcast hosted by Josh Herigon and Jason Newland discussing the intersection of medicine and technology info@medi.io Weekly podcast hosted by Josh Herigon and Jason Newland discussing the intersection of medicine and technology no podcast - mediio http://www.medi.io/episode/ Tue, 09 Jun 2020 03:11:50 +0000 en Site-Server v6.0.0-29945-29945 (http://www.squarespace.com) Josh Herigon Weekly podcast about medicine, technology, social media, and design no info@medi.io 003: A time for change Josh Herigon Tue, 09 Jun 2020 03:20:47 +0000 https://feedpress.me/link/5648/13613084/003-a-time-for-change 527bf3e8e4b0495cc4f3ce6e:527bf45de4b0cb566ecfa4df:5edefdf54d8ef51fb0ad591d Josh and Jason are joined this week by Kris Bryant, current president of the Pediatric Infectious Diseases Society. Our discussion ranges from fellowship and recruitment in the context of Covid–19 to how to address structural racism as a pediatric infectious diseases community.

Links for this episode:

Have a question or comment? Drop us a line on our feedback form or send Josh or Jason a tweet.

Listen on Apple Podcasts

]]> mediio Josh and Jason are joined this week by Kris Bryant, current president of the Pediatric Infectious Diseases Society. Our discussion ranges from fellowship and recruitment in the context of Covid-19 to how to address structural racism as a pediatric infectious diseases community. no 00:42:39 1 3 003: A time for change full 003: A time for change Josh and Jason are joined this week by Kris Bryant, current president of the Pediatric Infectious Diseases Society. Our discussion ranges from fellowship and recruitment in the context of Covid–19 t… 002: One health Josh Herigon Fri, 05 Jun 2020 19:20:07 +0000 https://feedpress.me/link/5648/13606284/002-one-health 527bf3e8e4b0495cc4f3ce6e:527bf45de4b0cb566ecfa4df:5eda99a9f8b7382d01adc51b Josh and Jason are joined this week by Andrej Spec to further discuss the data coming out on remdesivir, specifically the recently released trial examining 5 days of therapy versus 10 days. They also hit on how we are all connected through health and the need for justice.

Links for this episode:

Have a question or comment? Drop us a line on our feedback form or send Josh or Jason a tweet.

Listen on Apple Podcasts

]]> mediio Josh and Jason are joined this week by Andrej Spec Josh and Jason are joined this week by Andrej Spec to discuss more about the data coming out on remdesivir, specifically the recently release trial examining 5 days of therapy versus 10 days. They also hit on how we are all connected through health and the need for justice. no 00:30:29 1 2 002: One health full 002: One health 001: We're back!! Josh Herigon Mon, 25 May 2020 14:23:19 +0000 https://feedpress.me/link/5648/13570760/001-were-back 527bf3e8e4b0495cc4f3ce6e:527bf45de4b0cb566ecfa4df:5ecbd2af02f4af1d189b4888 Josh and Jason return to podcasting and discuss the recently released New England Journal paper on remdesivir for Covid-19.

Links for this episode:

Have a question or comment? Drop us a line on our feedback form or send Josh or Jason a tweet.

Listen on Apple Podcasts

]]> mediio Josh and Jason return to podcasting. Josh and Jason return to podcasting and discuss the recently released New England Journal paper on remdesivir for Covid-19. no 00:35:41 1 1 001: We're back!! full 001: We're back!!